Cargando…

Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines

BACKGROUND: The PARADIGM consortium aimed to make patient engagement in the development and lifecycle management of medicines easier and more effective for all, with the development of new tools that fulfil robustly defined gaps where engagement is suboptimal. AIMS: To generate an inventory of gaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Faulkner, S. D., Pittens, C. A. C. M., Goedhart, N. S., Davies, E. H., Manning, E., Diaz-Ponce, A., Jose Vicente Edo, Maria, Prieto-Remón, L., Husain, L., Huberman, K., Boudes, M., Subramaniam, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492561/
https://www.ncbi.nlm.nih.gov/pubmed/34181236
http://dx.doi.org/10.1007/s43441-021-00313-9
_version_ 1784578939757264896
author Faulkner, S. D.
Pittens, C. A. C. M.
Goedhart, N. S.
Davies, E. H.
Manning, E.
Diaz-Ponce, A.
Jose Vicente Edo, Maria
Prieto-Remón, L.
Husain, L.
Huberman, K.
Boudes, M.
Subramaniam, M.
author_facet Faulkner, S. D.
Pittens, C. A. C. M.
Goedhart, N. S.
Davies, E. H.
Manning, E.
Diaz-Ponce, A.
Jose Vicente Edo, Maria
Prieto-Remón, L.
Husain, L.
Huberman, K.
Boudes, M.
Subramaniam, M.
author_sort Faulkner, S. D.
collection PubMed
description BACKGROUND: The PARADIGM consortium aimed to make patient engagement in the development and lifecycle management of medicines easier and more effective for all, with the development of new tools that fulfil robustly defined gaps where engagement is suboptimal. AIMS: To generate an inventory of gaps in patient engagement practices and process from existing global examples. METHODS: A large set of criteria for effective patient engagement previously defined via a multi-stakeholder Delphi method, were mapped under fourteen overarching themes. A gap analysis was then performed by twenty-seven reviewers against the resulting forty-six mapped criteria, on a sample of seventy initiatives from global databases. RESULTS: An inventory of gaps was identified including contextual information as to why the gaps exist. Our work identified general patterns where patient engagement was suboptimal—defined as; fragmented reporting and dissemination of patient engagement activities, and the fundamental principles defined in frameworks or guidance being poorly adhered to in actual practice. Specific gaps were identified for sixteen criteria. Additionally, it was also common to observe primary aspects of a process were addressed for a given criteria (i.e. training for roles and responsibilities) but a secondary context element was lacking (i.e. making training material accessible/understandable/meaningful to all participants). CONCLUSION: The results show that the evolution towards meaningful and systematic patient engagement is occurring, yet more importantly they provide clear directional insights to help enhance collaborative practices and co-design solutions. This targeted impact to catalyse a needs-oriented health system that integrates patient engagement at its core is essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43441-021-00313-9.
format Online
Article
Text
id pubmed-8492561
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84925612021-10-15 Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines Faulkner, S. D. Pittens, C. A. C. M. Goedhart, N. S. Davies, E. H. Manning, E. Diaz-Ponce, A. Jose Vicente Edo, Maria Prieto-Remón, L. Husain, L. Huberman, K. Boudes, M. Subramaniam, M. Ther Innov Regul Sci Original Research BACKGROUND: The PARADIGM consortium aimed to make patient engagement in the development and lifecycle management of medicines easier and more effective for all, with the development of new tools that fulfil robustly defined gaps where engagement is suboptimal. AIMS: To generate an inventory of gaps in patient engagement practices and process from existing global examples. METHODS: A large set of criteria for effective patient engagement previously defined via a multi-stakeholder Delphi method, were mapped under fourteen overarching themes. A gap analysis was then performed by twenty-seven reviewers against the resulting forty-six mapped criteria, on a sample of seventy initiatives from global databases. RESULTS: An inventory of gaps was identified including contextual information as to why the gaps exist. Our work identified general patterns where patient engagement was suboptimal—defined as; fragmented reporting and dissemination of patient engagement activities, and the fundamental principles defined in frameworks or guidance being poorly adhered to in actual practice. Specific gaps were identified for sixteen criteria. Additionally, it was also common to observe primary aspects of a process were addressed for a given criteria (i.e. training for roles and responsibilities) but a secondary context element was lacking (i.e. making training material accessible/understandable/meaningful to all participants). CONCLUSION: The results show that the evolution towards meaningful and systematic patient engagement is occurring, yet more importantly they provide clear directional insights to help enhance collaborative practices and co-design solutions. This targeted impact to catalyse a needs-oriented health system that integrates patient engagement at its core is essential. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s43441-021-00313-9. Springer International Publishing 2021-06-28 2021 /pmc/articles/PMC8492561/ /pubmed/34181236 http://dx.doi.org/10.1007/s43441-021-00313-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Faulkner, S. D.
Pittens, C. A. C. M.
Goedhart, N. S.
Davies, E. H.
Manning, E.
Diaz-Ponce, A.
Jose Vicente Edo, Maria
Prieto-Remón, L.
Husain, L.
Huberman, K.
Boudes, M.
Subramaniam, M.
Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
title Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
title_full Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
title_fullStr Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
title_full_unstemmed Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
title_short Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines
title_sort optimising multi-stakeholder practices in patient engagement: a gap analysis to enable focused evolution of patient engagement in the development and lifecycle management of medicines
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492561/
https://www.ncbi.nlm.nih.gov/pubmed/34181236
http://dx.doi.org/10.1007/s43441-021-00313-9
work_keys_str_mv AT faulknersd optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT pittenscacm optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT goedhartns optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT davieseh optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT manninge optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT diazponcea optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT josevicenteedomaria optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT prietoremonl optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT husainl optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT hubermank optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT boudesm optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines
AT subramaniamm optimisingmultistakeholderpracticesinpatientengagementagapanalysistoenablefocusedevolutionofpatientengagementinthedevelopmentandlifecyclemanagementofmedicines